Refining the impact of genetic evidence on clinical success

Eric Vallabh Minikel, Jeffery L Painter, Coco Chengliang Dong, Matthew R. Nelson
doi: https://doi.org/10.1101/2023.06.23.23291765

Article Information

doi 
https://doi.org/10.1101/2023.06.23.23291765
History 
  • December 19, 2023.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Eric Vallabh Minikel1,
  2. Jeffery L Painter2,*,
  3. Coco Chengliang Dong3 and
  4. Matthew R. Nelson3,4,†
  1. 1Stanley Center for Psychiatric Research, Broad Institute, Cambridge, MA 02142
  2. 2JiveCast, Raleigh, NC, 27601
  3. 3Deerfield Management Company, L.P., New York, NY 10010
  4. 4Genscience LLC, New York, NY 10010
  1. ↵†Corresponding author: mnelson{at}genscience.com

  • ↵* GlaxoSmithKline, Research Triangle Park, NC 27709

Back to top
Posted December 19, 2023.
Download PDF

Supplementary Material

Data/Code
Email
Refining the impact of genetic evidence on clinical success
Eric Vallabh Minikel, Jeffery L Painter, Coco Chengliang Dong, Matthew R. Nelson
medRxiv 2023.06.23.23291765; doi: https://doi.org/10.1101/2023.06.23.23291765
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area